Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.
about
Matrix rigidity regulates cancer cell growth and cellular phenotype.Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transitionmiR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cellsRegulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transitionCancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?Role of DeltaNp63gamma in epithelial to mesenchymal transitionCancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentMechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionHomeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer ProgressionEchoes of the embryo: using the developmental biology toolkit to study cancerEpithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbanceEpithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaMetastatic cancer stem cells: from the concept to therapeuticsFunctional Role of the microRNA-200 Family in Breast Morphogenesis and NeoplasiaTargeting TGF-β signaling in cancerWound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancerA cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinomaAngiotensin II contributes to renal fibrosis independently of Notch pathway activationPy2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivoSmad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesisTGF-β family signaling in stem cellsTGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transitionA 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug developmentCurcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMTTargeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres FormationTGF-β-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-ATGF-beta-induced epithelial to mesenchymal transitionA complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transitionDifferences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes.Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulationComplete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathwayMolecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.TGF-beta biology in mammary development and breast cancer.Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells.
P2860
Q21562167-19B8D711-5195-49FB-AF1F-B17CBF29931FQ22000749-8DC8D6C7-7641-4615-A033-BC83D7DF7BB5Q24318681-805E89F1-16D3-4FAB-819C-7DBB1A91E724Q24613084-4DC15E10-2B63-42D2-9228-6BC8880D62CFQ24623118-D0FDBFF4-4152-417D-9A90-ECF4A2BEFC62Q24628819-1EDD2791-B9CF-415A-BBA2-9090FAD4DB68Q24632945-D040112D-29DF-436F-A3D3-837F103D6447Q26740619-7BBBC04D-C4EC-428E-BF90-12375D0F50BFQ26745545-CC2781FF-224D-4084-8FC5-BA187F079C06Q26768428-CCF989BA-CB0C-46F1-8AA6-42E21C90E7ECQ26770157-11ED5B2F-FC23-4DFF-9DA6-51588975864BQ26826431-B8251964-E1DE-45DC-A144-5B98CAA0637EQ26849546-B8AFD4F4-2CD1-4AD0-BD7D-CA334B58A1E7Q26850739-22064E84-81D8-4768-89DD-C33319DB4940Q26861636-4B1AD085-4DEA-4ABE-8FF6-F57600E25718Q27012443-C957487B-750F-4B94-A51D-82C11A0DE83BQ27023599-CE0AEAEE-AB1C-4507-B3C9-62106E25A505Q27307150-E6ED0FE0-04B7-4534-8E33-8F2642408E14Q27334791-12541C9E-857A-4214-A228-67A6A7D3EAADQ27340972-04CE6F13-A05A-4CF2-ACF3-C575BDF493B4Q28267699-44BAFA0B-1601-466C-AC18-17FC25857889Q28274611-F69CF8DE-C01F-44EB-871F-1AB002208D34Q28512991-D945A2D8-2A96-4E2D-B5AB-81CA30433FE6Q28534459-5984FCE7-0DD7-469B-AD66-19E95FB41D27Q28543093-863F3EE3-0FF5-4152-83E3-22C5CE68A839Q28552789-AEC5C2B8-07BC-410B-B87B-49B70A9F2F54Q28591018-38E97E66-0F63-4BAE-9ECB-2F091B9E7267Q29619820-C1B14506-8B03-4EFF-81F8-C471BA868263Q30416855-0D05BFE8-37D9-4D0C-9FB9-03D92BB736C5Q30422043-01D0C7ED-6AB7-4DED-AA92-83A39080D2AEQ30841647-75996A4A-D7DD-491C-ABC8-C28303386BADQ33350614-46AF4155-71C2-49E4-9398-32A5B7A85C33Q33405240-0B51CF28-E404-4817-AF0C-CD1102C0A6DDQ33481999-6311752A-5773-41B9-9976-C421D4173FFEQ33482559-9044DEBD-81E6-4567-BFED-CE5232803E96Q33520113-0942B65E-761C-4D38-B213-89E197E7F744Q33566627-7E353872-5C4B-4EB7-9488-1AAFD4E9E56AQ33613286-78368CA8-74B4-4251-B41A-AAFAE13E722DQ33681686-2603BA98-FF79-400F-A0D5-D2BFC81ECAC6Q33682955-AE84A08A-B4ED-4606-ADAB-05EB12357DC1
P2860
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Signaling networks guiding epi ...... enesis and cancer progression.
@ast
Signaling networks guiding epi ...... enesis and cancer progression.
@en
Signaling networks guiding epi ...... enesis and cancer progression.
@nl
type
label
Signaling networks guiding epi ...... enesis and cancer progression.
@ast
Signaling networks guiding epi ...... enesis and cancer progression.
@en
Signaling networks guiding epi ...... enesis and cancer progression.
@nl
prefLabel
Signaling networks guiding epi ...... enesis and cancer progression.
@ast
Signaling networks guiding epi ...... enesis and cancer progression.
@en
Signaling networks guiding epi ...... enesis and cancer progression.
@nl
P1433
P1476
Signaling networks guiding epi ...... enesis and cancer progression.
@en
P2093
Carl-Henrik Heldin
P304
P356
10.1111/J.1349-7006.2007.00550.X
P577
2007-07-23T00:00:00Z